Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment

1.

Aarsland D, Saeedzadeh-Sardahaee F, Anderssen S, Ballard C (2010) Is physical activity a potential preventive factor for vascular dementia? A systematic review. Aging Ment Health. https://doi.org/10.1080/13607860903586136CrossRefPubMed

2.

Abbruscato T, Davis T (1999) Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact. Brain Res 842:277–286. https://doi.org/10.1016/S0006-8993(99)01778-3CrossRefPubMed

3.

Abraham JM, Cho L (2010) The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 77:911–918. https://doi.org/10.3949/ccjm.77a.10036CrossRefPubMed

4.

Aevarsson Ó, Svanborg A, Skoog I (1998) Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol 55:1226–1232. https://doi.org/10.1001/ARCHNEUR.55.9.1226CrossRefPubMed

5.

Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B (1999) Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol 52:737–743. https://doi.org/10.1016/S0895-4356(99)00067-0CrossRefPubMed

6.

András IE, Deli MA, Veszelka S, Hayashi K, Hennig B, Toborek M (2007) The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab 27:1431–1443. https://doi.org/10.1038/SJ.JCBFM.9600445CrossRefPubMed

7.

Anjum I, Fayyaz M, Wajid A, Sohail W, Ali A (2018) Does obesity increase the risk of dementia: a literature review. Cureus 10:e2660. https://doi.org/10.7759/cureus.2660CrossRefPubMedPubMedCentral

8.

Anstey KJ, von Sanden C, Salim A, O’Kearney R (2007) Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 166:367–378. https://doi.org/10.1093/aje/kwm116CrossRefPubMed

9.

Appleton JP, Scutt P, Sprigg N, Bath PM (2017) Hypercholesterolaemia and vascular dementia. Clin Sci 131:1561–1578. https://doi.org/10.1042/cs20160382CrossRef

10.

Arai K, Lo EH (2010) Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res 88:758–763. https://doi.org/10.1002/jnr.22256CrossRefPubMedPubMedCentral

11.

Arguin H, Dionne IJ, Sénéchal M, Bouchard DR, Carpentier AC, Ardilouze J-L, Tremblay A, Leblanc C, Brochu M (2012) Short- and long-term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: a pilot study. Menopause 19:870CrossRefPubMed

12.

Arnoldussen IA, Kiliaan AJ, Gustafson DR (2014) Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol 24:1982–1999. https://doi.org/10.1016/j.euroneuro.2014.03.002CrossRefPubMedPubMedCentral

13.

Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R (1990) Women, myocardial infarction, and dementia in the very old. Neurology 40:1102–1106. https://doi.org/10.1212/wnl.40.7.1102CrossRefPubMed

14.

Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34:325–337. https://doi.org/10.1016/S0143-4160(03)00141-6CrossRefPubMed

15.

Babcock AA, Kuziel WA, Rivest S, Owens T (2003) Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922–7930. https://doi.org/10.1523/JNEUROSCI.23-21-07922.2003CrossRefPubMedPubMedCentral

16.

Baik SH, Selvaraji S, Fann DY, Poh L, Jo DG, Herr DR, Zhang SR, Kim HA, Silva M, Lai MKP et al (2021) Hippocampal transcriptome profiling reveals common disease pathways in chronic hypoperfusion and aging. Aging (Albany NY) 13:14651–14674. https://doi.org/10.18632/aging.203123CrossRefPubMed

17.

Bakhru A, Erlinger TP (2005) Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2:e160. https://doi.org/10.1371/journal.pmed.0020160CrossRefPubMedPubMedCentral

18.

Bakker SLM, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MMB (1999) Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 52:578–578. https://doi.org/10.1212/WNL.52.3.578CrossRefPubMed

19.

Barić D (2014) Why pulsatility still matters: a review of current knowledge. Croat Med J 55:609–620. https://doi.org/10.3325/cmj.2014.55.609CrossRefPubMedPubMedCentral

20.

Barna BP, Pettay J, Barnett GH, Zhou P, Iwasaki K, Estes ML (1994) Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J Neuroimmunol 50:101–107. https://doi.org/10.1016/0165-5728(94)90220-8CrossRefPubMed

21.

Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA (2012) Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69:493–498. https://doi.org/10.1001/archgenpsychiatry.2011.1481CrossRefPubMedPubMedCentral

22.

Barreras A, Gurk-Turner C (2003) Angiotensin II receptor blockers. In: Baylor University Medical Center Proceedings, vol 16, pp 123–126. https://doi.org/10.1080/08998280.2003.11927893

23.

Barreto G, White RE, Ouyang Y, Xu L, Giffard RG (2011) Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 11:164–173. https://doi.org/10.2174/187152411796011303CrossRefPubMedPubMedCentral

24.

Belkhelfa M, Beder N, Mouhoub D, Amri M, Hayet R, Nabila T, Bakhti S, Laimouche S, Azzouz D, Belhadj R et al (2018) The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia. J Neuroimmunol. https://doi.org/10.1016/j.jneuroim.2018.04.004CrossRefPubMed

25.

Ben Ari H, Lifschytz T, Wolf G, Rigbi A, Blumenfeld-Katzir T, Kreisel Merzel T, Koroukhov N, Lotan A, Lerer B (2019) White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion. Brain Res. https://doi.org/10.1016/j.brainres.2019.01.017CrossRefPubMed

26.

Bennett S, Grant MM, Aldred S (2009) Oxidative stress in vascular dementia and Alzheimer’s disease: a common pathology. J Alzheimers Dis 17:245–257. https://doi.org/10.3233/JAD-2009-1041CrossRefPubMed

27.

Bennett SA, Tenniswood M, Chen JH, Davidson CM, Keyes MT, Fortin T, Pappas BA (1998) Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment. NeuroReport 9:161–166. https://doi.org/10.1097/00001756-199801050-00033CrossRefPubMed

28.

Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44:999–1010. https://doi.org/10.1016/j.molimm.2006.03.007CrossRefPubMed

29.

Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MH (1993) Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 60:1964–1967. https://doi.org/10.1111/j.1471-4159.1993.tb13430.xCrossRefPubMed

30.

Breteler MM, Claus JJ, Grobbee DE, Hofman A (1994) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ 308:1604–1608. https://doi.org/10.1136/bmj.308.6944.1604CrossRefPubMedPubMedCentral

31.

Brown MD, Wallace DC (1994) Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr 26:273–289. https://doi.org/10.1007/BF00763099CrossRefPubMed

32.

Brown RC, Davis TP (2002) Calcium modulation of adherens and tight junction function. Stroke 33:1706–1711. https://doi.org/10.1161/01.STR.0000016405.06729.83CrossRefPubMed

33.

Brown WR, Moody DM, Thore CR, Challa VR (2000) Apoptosis in leukoaraiosis. Am J Neuroradiol 21:79–82PubMedPubMedCentral

34.

Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37:56–74. https://doi.org/10.1111/j.1365-2990.2010.01139.xCrossRefPubMedPubMedCentral

35.

Brun A (1994) Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dement Geriatr Cogn Disord 5:145–147. https://doi.org/10.1159/000106712CrossRef

36.

Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm 7:433–437. https://doi.org/10.1016/j.hrthm.2009.12.004CrossRefPubMed

37.

Byers AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol 7:323–331. https://doi.org/10.1038/nrneurol.2011.60CrossRefPubMedPubMedCentral

38.

Camacho A, Massieu L (2006) Role of glutamate transporters in the clearance and release of glutamate during Ischemia and its relation to neuronal death. Arch Med Res 37:11–18. https://doi.org/10.1016/j.arcmed.2005.05.014CrossRefPubMed

39.

Campolo J, De Maria R, Mariotti C, Tomasello C, Parolini M, Frontali M, Inzitari D, Valenti R, Federico A, Taroni F et al (2013) Is the oxidant/antioxidant status altered in CADASIL patients? PLoS ONE 8:e67077–e67077. https://doi.org/10.1371/journal.pone.0067077CrossRefPubMedPubMedCentral

40.

Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, Prestopnik J, Wills J, Rosenberg GA (2011) Matrix metalloproteinases are associated with increased blood–brain barrier opening in vascular cognitive impairment. Stroke 42:1345–1350. https://doi.org/10.1161/STROKEAHA.110.600825CrossRefPubMedPubMedCentral

41.

Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Bosi C, Brombo G, Pugliatti M, Seripa D, Zuliani G et al (2019) Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer’s disease and mild cognitive impairment. Sci Rep 9:20009–20009. https://doi.org/10.1038/s41598-019-56614-5CrossRefPubMedPubMedCentral

42.

Catindig J-AS, Venketasubramanian N, Ikram MK, Chen C (2012) Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci 321:11–16CrossRefPubMed

43.

Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, Mestriner R, Weis SN, Netto CA (2012) Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull 87:109–116. https://doi.org/10.1016/j.brainresbull.2011.10.006CrossRefPubMed

44.

Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Bergamini CM, Valacchi G, Pilotto A, Zuliani G (2014) Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment. Biomed Res Int 2014:309507–309507. https://doi.org/10.1155/2014/309507CrossRefPubMedPubMedCentral

45.

Chai YL, Hilal S, Chong JR, Ng YX, Liew OW, Xu X, Ikram MK, Venketasubramanian N, Richards AM, Lai MKP et al (2016) Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine 95:e4566. https://doi.org/10.1097/MD.0000000000004566CrossRefPubMedPubMedCentral

46.

Chai YL, Rajeev V, Poh L, Selvaraji S, Hilal S, Chen CP, Jo DG, Koo EH, Arumugam TV, Lai MK (2022) Chronic cerebral hypoperfusion alters the CypA-EMMPRIN-gelatinase pathway: implications for vascular dementia. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678x221146401CrossRefPubMed

47.

Che H, Yan Y, Kang X-H, Guo F, Yan M-L, Liu H-L, Hou X, Liu T, Zong D-K, Sun L-L et al (2017) MicroRNA-27a promotes inefficient lysosomal clearance in the hippocampi of rats following chronic brain hypoperfusion. Mol Neurobiol 54:2595–2610. https://doi.org/10.1007/s12035-016-9856-8CrossRefPubMed

48.

Chen C, Homma A, Mok VCT, Krishnamoorthy E, Alladi S, Meguro K, Abe K, Dominguez J, Marasigan S, Kandiah N (2016) Alzheimer’s disease with cerebrovascular disease: current status in the Asia–Pacific region. J Intern Med 280:359–374CrossRefPubMed

49.

Chen CPLH (2004) Transcultural expression of subcortical vascular disease. J Neurol Sci 226:45–47. https://doi.org/10.1016/j.jns.2004.09.010CrossRefPubMed

50.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204–7218. https://doi.org/10.18632/oncotarget.23208CrossRefPubMedPubMedCentral

51.

Chen Y, Guo Z, Peng X, Xie W, Chen L, Tan Z (2018) Nimodipine represses AMPK phosphorylation and excessive autophagy after chronic cerebral hypoperfusion in rats. Brain Res Bull 140:88–96. https://doi.org/10.1016/j.brainresbull.2018.03.019CrossRefPubMed

52.

Chew KA, Xu X, Siongco P, Villaraza S, Phua AKS, Wong ZX, Chung CY, Tang N, Chew E, Henry CJ et al (2021) SINgapore GERiatric intervention study to reduce physical frailty and cognitive decline (SINGER)-pilot: a feasibility study. Alzheimers Dement (NY) 7:e12141. https://doi.org/10.1002/trc2.12141CrossRef

53.

Choi DH, Lee KH, Kim JH, Seo JH, Kim HY, Shin CY, Han JS, Han SH, Kim YS, Lee J (2014) NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxid Redox Signal 21:533–550. https://doi.org/10.1089/ars.2012.5129CrossRefPubMedPubMedCentral

54.

Choi JC (2015) Genetics of cerebral small vessel disease. J Stroke 17:7–16. https://doi.org/10.5853/jos.2015.17.1.7CrossRefPubMedPubMedCentral

55.

Chrissobolis S, Banfi B, Sobey CG, Faraci FM (2012) Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J Appl Physiol 113:184–191. https://doi.org/10.1152/JAPPLPHYSIOL.00455.2012CrossRefPubMed

56.

Ciacciarelli A, Sette G, Giubilei F, Orzi F (2020) Chronic cerebral hypoperfusion: an undefined, relevant entity. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.01.026CrossRefPubMed

57.

Cipollini V, Troili F, Giubilei F (2019) Emerging biomarkers in vascular cognitive impairment and dementia: from pathophysiological pathways to clinical application. Int J Mol Sci 20:2812–2812. https://doi.org/10.3390/ijms20112812CrossRefPubMedPubMedCentral

58.

Colcombe S, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 14:125–130. https://doi.org/10.1111/1467-9280.t01-1-01430CrossRefPubMed

59.

Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP (2002) Neutrophil-derived Glutamate regulates vascular endothelial barrier function. J Biol Chem 277:14801–14811. https://doi.org/10.1074/JBC.M110557200CrossRefPubMed

60.

Corrada MM, Brookmeyer R, Berlau D, Paganini-Hill A, Kawas CH (2008) Prevalence of dementia after age 90: results from the 90+ study. Neurology 71:337–343. https://doi.org/10.1212/01.wnl.0000310773.65918.cdCrossRefPubMed

61.

Corraini P, Henderson VW, Ording AG, Pedersen L, Horváth-Puhó E, Sørensen HT (2017) Long-term risk of dementia among survivors of ischemic or hemorrhagic stroke. Stroke 48:180–186. https://doi.org/10.1161/strokeaha.116.015242CrossRefPubMed

62.

Courties G, Moskowitz MA, Nahrendorf M (2014) The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol 71:233–236. https://doi.org/10.1001/jamaneurol.2013.5026CrossRefPubMedPubMedCentral

63.

Daneman R, Prat A (2015) The blood–brain barrier. Cold Spring Harb Perspect Biol 7:a020412. https://doi.org/10.1101/CSHPERSPECT.A020412CrossRefPubMed

64.

Datta A, Qian J, Chong R, Kalaria RN, Francis P, Lai MKP, Chen CP, Sze SK (2014) Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia. J Proteom 99:54–67. https://doi.org/10.1016/j.jprot.2014.01.011CrossRef

65.

de Cabo R, Mattson MP (2019) Effects of intermittent fasting on health, aging, and disease. N Engl J Med 381:2541–2551. https://doi.org/10.1056/NEJMra1905136CrossRefPubMed

66.

de la Torre JC (2012) Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012:367516. https://doi.org/10.1155/2012/367516CrossRefPubMedPubMedCentral

67.

De Silva TM, Faraci FM (2016) Microvascular dysfunction and cognitive impairment. Cell Mol Neurobiol 36:241–258. https://doi.org/10.1007/s10571-015-0308-1CrossRefPubMedPubMedCentral

68.

De Vivo DC (1993) The expanding clinical spectrum of mitochondrial diseases. Brain Dev 15:1–22. https://doi.org/10.1016/0387-7604(93)90002-PCrossRefPubMed

69.

Del Ser T, Hachinski V, Merskey H, Munoz DG (1999) An autopsy-verified study of the effect of education on degenerative dementia. Brain 122(Pt 12):2309–2319. https://doi.org/10.1093/brain/122.12.2309CrossRefPubMed

70.

Ding Q, Dimayuga E, Keller JN (2006) Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal 8:163–172. https://doi.org/10.1089/ars.2006.8.163CrossRefPubMed

71.

Dong J, Zhao J, Lin Y, Liang H, He X, Zheng X, Sui M, Zhuang Z, Yan T (2018) Exercise improves recognition memory and synaptic plasticity in the prefrontal cortex for rats modelling vascular dementia. Neurol Res 40:68–77. https://doi.org/10.1080/01616412.2017.1398389CrossRefPubMed

72.

Du J, Ma M, Zhao Q, Fang L, Chang J, Wang Y, Fei R, Song X (2012) Mitochondrial bioenergetic deficits in the hippocampus of rats with chronic Ischemia-induced vascular dementia. Neuroscience. https://doi.org/10.1016/j.neuroscience.2012.11.062CrossRefPubMedPubMedCentral

73.

Duits FH, Hernandez-Guillamon M, Montaner J, Goos JDC, Montañola A, Wattjes MP, Barkhof F, Scheltens P, Teunissen CE, van der Flier WM (2015) Matrix metalloproteinases in Alzheimer’s disease and concurrent cerebral microbleeds. J Alzheimer’s Dis 48:711–720. https://doi.org/10.3233/JAD-143186CrossRef

74.

Duncombe J, Kitamura A, Hase Y, Ihara M, Kalaria Raj N, Horsburgh K (2017) Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci 131:2451–2468. https://doi.org/10.1042/CS20160727CrossRef

75.

Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4:363–381. https://doi.org/10.2147/vhrm.s1839CrossRefPubMedPubMedCentral

76.

Enciu A-M, Constantinescu SN, Popescu LM, Mureşanu DF, Popescu BO (2011) Neurobiology of vascular dementia. J Aging Res 2011:401604. https://doi.org/10.4061/2011/401604CrossRefPubMedPubMedCentral

77.

Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JCM, Breteler MMB (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61:668–672. https://doi.org/10.1001/archneur.61.5.668CrossRefPubMed

78.

Erhardt EB, Pesko JC, Prestopnik J, Thompson J, Caprihan A, Rosenberg GA (2018) Biomarkers identify the Binswanger type of vascular cognitive impairment. J Cereb Blood Flow Metab 39:1602–1612. https://doi.org/10.1177/0271678X18762655CrossRef

79.

Esposito M, Sherr GL (2019) Epigenetic modifications in Alzheimer’s neuropathology and therapeutics. Front Neurosci 13:476–476. https://doi.org/10.3389/fnins.2019.00476CrossRefPubMedPubMedCentral

80.

Famulari AL, Marschoff ER, Llesuy SF, Kohan S, Serra JA, Domínguez RO, Repetto MG, Reides CG, de Lustig ES (1996) The antioxidant enzymatic blood profile in Alzheimer’s and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls. J Neurol Sci 141:69–78CrossRefPubMed

81.

Fan Y, Ou X, Wang W, Tian X, Yan S, Hu N, Zhang X, Xing W (2017) Identification and analysis of toll like receptor 4 (TLR4) level changes in vascular dementia patients related type 2 diabetes mellitus. Biomed Res 28:4588

82.

Fann DY-W, Lee S-Y, Manzanero S, Chunduri P, Sobey CG, Arumugam TV (2013) Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev 12:941–966. https://doi.org/10.1016/j.arr.2013.09.004CrossRefPubMed

83.

Faraci F (2006) Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol 100:739–743. https://doi.org/10.1152/japplphysiol.01044.2005CrossRefPubMed

84.

Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V (2012) Role of apoptosis in disease. Aging 4:330–349. https://doi.org/10.18632/aging.100459CrossRefPubMedPubMedCentral

85.

Fernando HA, Zibellini J, Harris RA, Seimon RV, Sainsbury A (2019) Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients 11:478–478. https://doi.org/10.3390/nu11020478CrossRefPubMedPubMedCentral

86.

Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton SB et al (2006) White matter lesions in an unselected cohort of the elderly. Stroke 37:1391–1398. https://doi.org/10.1161/01.STR.0000221308.94473.14CrossRefPubMed

87.

Filley CM (2021) Cognitive dysfunction in white matter disorders: new perspectives in treatment and recovery. J Neuropsychiatry Clin Neurosci 33:349–355. https://doi.org/10.1176/appi.neuropsych.21030080CrossRefPubMed

88.

Fischer S, Wobben M, Kleinstück J, Renz D, Schaper W (2000) Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells. Am J Physiol Cell Physiol 279:C935–C944. https://doi.org/10.1152/ajpcell.2000.279.4.C935CrossRefPubMed

89.

Förstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflüg Arch Eur J Physiol 459(6):923–939. https://doi.org/10.1007/S00424-010-0808-2CrossRef

90.

Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM, Faris P, Anderson T, Galbraith D, Parboosingh JS, Ghali WA et al (2012) A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen Psychiatry 69:244–255. https://doi.org/10.1001/archgenpsychiatry.2011.1361CrossRefPubMed

91.

French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB (2009) Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87:3076–3087. https://doi.org/10.1002/jnr.22139CrossRefPubMedPubMedCentral

92.

Friedman L (2007) CALCIUM: a role for neuroprotection and sustained adaptation. Mol Interv 6:315–329. https://doi.org/10.1124/mi.6.6.5CrossRef

93.

Fünfschilling U, Supplie L, Mahad D, Boretius S, Saab A, Edgar J, Brinkmann B, Kassmann C, Tzvetanova I, Möbius W et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517–521. https://doi.org/10.1038/nature11007CrossRefPubMedPubMedCentral

94.

Gannon OJ, Robison LS, Custozzo AJ, Zuloaga KL (2019) Sex differences in risk factors for vascular contributions to cognitive impairment & dementia. Neurochem Int 127:38–55. https://doi.org/10.1016/j.neuint.2018.11.014CrossRefPubMed

95.

Gemma C, Vila J, Bachstetter A, Bickford PC (2007) Oxidative stress and the aging brain: from theory to prevention. CRC Press/Routledge/Taylor & Francis Group, pp 353–374

96.

González-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778:729–756. https://doi.org/10.1016/J.BBAMEM.2007.08.018CrossRefPubMed

97.

Gordon P, Flanagan P (2016) Smoking: a risk factor for vascular disease. J Vasc Nurs 34:79–86. https://doi.org/10.1016/j.jvn.2016.04.001CrossRefPubMed

98.

Gorelick PB (2004) Risk factors for vascular dementia and Alzheimer disease. Stroke 35:2620–2622. https://doi.org/10.1161/01.Str.0000143318.70292.47CrossRefPubMed

99.

Gorelick PB, Counts SE, Nyenhuis D (2016) Vascular cognitive impairment and dementia. Biochim Biophys Acta (BBA) Mol Basis Dis 1862:860–868. https://doi.org/10.1016/j.bbadis.2015.12.015CrossRef

100.

Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672–2713. https://doi.org/10.1161/STR.0b013e3182299496CrossRefPubMedPubMedCentral

101.

Graban A, Bednarska-Makaruk M, Bochyńska A, Lipczyńska-Łojkowska W, Ryglewicz D, Wehr H (2009) Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD). J Neurol Sci 283:116–118. https://doi.org/10.1016/j.jns.2009.02.344CrossRefPubMed

102.

Graeber MB, Grasbon-Frodl E, Eitzen UV, Kösel S (1998) Neurodegeneration and aging: role of the second genome. J Neurosci Res 52:1–6. https://doi.org/10.1002/(SICI)1097-4547(19980401)52:1%3c1::AID-JNR1%3e3.0.CO;2-ICrossRefPubMed

103.

Gray F, Polivka M, Viswanathan A, Baudrimont M, Bousser M-G, Chabriat H (2007) Apoptosis in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 66:597–607. https://doi.org/10.1097/nen.0b013e318093e574CrossRefPubMed

104.

Grimm A, Friedland K, Eckert A (2016) Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease. Biogerontology. https://doi.org/10.1007/s10522-015-9618-4CrossRefPubMed

105.

Grivennikov S, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21(1):11–19CrossRefPubMed

106.

Gyanwali B, Lai MKP, Lui B, Liew OW, Venketasubramanian N, Richards AM, Chen C, Hilal S (2021) Blood-based cardiac biomarkers and the risk of cognitive decline, cerebrovascular disease, and clinical events. Stroke 52:2275–2283. https://doi.org/10.1161/strokeaha.120.032571CrossRefPubMed

107.

Gyanwali B, Shaik MA, Tan BY, Venketasubramanian N, Chen C, Hilal S (2019) Risk factors for and clinical relevance of incident and progression of cerebral small vessel disease markers in an Asian memory clinic population. J Alzheimer’s Dis 67:1209–1219. https://doi.org/10.3233/JAD-180911CrossRef

108.

Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN et al (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37:2220–2241. https://doi.org/10.1161/01.STR.0000237236.88823.47CrossRefPubMed

109.

Hainsworth AH, Yeo NE, Weekman EM, Wilcock DM (2016) Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta 1862:1008–1017. https://doi.org/10.1016/j.bbadis.2015.11.015CrossRefPubMed

110.

Halberg N, Henriksen M, Söderhamn N, Stallknecht B, Ploug T, Schjerling P, Dela F (2005) Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol 99:2128–2136. https://doi.org/10.1152/japplphysiol.00683.2005CrossRefPubMed

111.

Halling A, Berglund J (2006) Association of diagnosis of ischaemic heart disease, diabetes mellitus and heart failure with cognitive function in the elderly population. Eur J Gen Pract 12:114–119. https://doi.org/10.1080/13814780600881128CrossRefPubMed

112.

Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y (2007) Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood–brain barrier dysfunction. J Neurochem 101:566–576. https://doi.org/10.1111/j.1471-4159.2006.04393.xCrossRefPubMed

113.

Harter K, Levine M, Henderson SO (2015) Anticoagulation drug therapy: a review. West J Emerg Med 16:11–17. https://doi.org/10.5811/westjem.2014.12.22933CrossRefPubMedPubMedCentral

114.

Hattori Y, Enmi J, Kitamura A, Yamamoto Y, Saito S, Takahashi Y, Iguchi S, Tsuji M, Yamahara K, Nagatsuka K et al (2015) A novel mouse model of subcortical infarcts with dementia. J Neurosci 35:3915–3928. https://doi.org/10.1523/jneurosci.3970-14.2015CrossRefPubMedPubMedCentral

115.

Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME (1995) Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 60:143–150. https://doi.org/10.1016/0165-5728(95)00064-9CrossRefPubMed

116.

Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF (2001) Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol 154:642–648. https://doi.org/10.1093/aje/154.7.642CrossRefPubMed

117.

Hénon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D (2001) Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57:1216–1222. https://doi.org/10.1212/wnl.57.7.1216CrossRefPubMed

118.

Hertz L (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55:289–309. https://doi.org/10.1016/j.neuropharm.2008.05.023CrossRefPubMed

119.

Hertz L, Dienel GA (2002) Energy metabolism in the brain. In: Dwyer D (ed) Glucose metabolism in the brain. Academic Press, pp 1–102

120.

Hetz C, Saxena S (2017) ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol 13:477–491. https://doi.org/10.1038/nrneurol.2017.99CrossRefPubMed

121.

High FA, Epstein JA (2008) The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet 9:49–61. https://doi.org/10.1038/nrg2279CrossRefPubMed

122.

Hilal S, Chai YL, van Veluw S, Shaik MA, Ikram MK, Venketasubramanian N, Richards AM, Biessels GJ, Chen C (2017) Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts. JAMA Neurol 74:403–410CrossRefPubMedPubMedCentral

123.

Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CLH (2017) Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry 88:669–674. https://doi.org/10.1136/JNNP-2016-315324CrossRefPubMed

124.

Ho SC, Woo J, Sham A, Chan SG, Yu ALM (2001) A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort. Int J Epidemiol 30:1389–1396. https://doi.org/10.1093/ije/30.6.1389CrossRefPubMed

125.

Hsu M-J, Sheu J-R, Lin C-H, Shen M-Y, Hsu CY (2010) Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta (BBA) Gen Subj 1800:290–296. https://doi.org/10.1016/j.bbagen.2009.08.003CrossRef

126.

Hu M, Liu Z, Lv P, Wang H, Zhu Y, Qi Q, Xu J (2017) Autophagy and Akt/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia. Behav Brain Res 325:79–86. https://doi.org/10.1016/j.bbr.2016.11.053CrossRefPubMed

127.

Huang J, Li J, Feng C, Huang X, Wong L, Liu X, Nie Z, Xi G (2018) Blood–brain barrier damage as the starting point of leukoaraiosis caused by cerebral chronic hypoperfusion and its involved mechanisms: effect of agrin and aquaporin-4. Biomed Res Int. https://doi.org/10.1155/2018/2321797CrossRefPubMedPubMedCentral

128.

Huang J, Zhang Z, Hong X, Wang J, Wei J, Wen H (2009) Early cognitive predictors of vascular dementia: a population-based longitudinal study in Chinese elderly. J Exp Stroke Transl Med. https://doi.org/10.4172/1939-067x.1000103CrossRef

129.

Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR et al (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063–2069. https://doi.org/10.2337/diabetes.49.12.2063CrossRefPubMed

130.

Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80:844–866. https://doi.org/10.1016/j.neuron.2013.10.008CrossRefPubMed

131.

Ikram MA, Bersano A, Manso-Calderón R, Jia JP, Schmidt H, Middleton L, Nacmias B, Siddiqi S, Adams HH (2017) Genetics of vascular dementia—review from the ICVD working group. BMC Med 15:48. https://doi.org/10.1186/s12916-017-0813-9CrossRefPubMedPubMedCentral

132.

Ingles JL, Wentzel C, Fisk JD, Rockwood K (2002) Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 33:1999–2002. https://doi.org/10.1161/01.STR.0000024433.36590.1BCrossRefPubMed

133.

Jagtap A, Gawande S, Sharma S (2015) Biomarkers in vascular dementia: a recent update. Biomark Genom Med 7:43–56. https://doi.org/10.1016/j.bgm.2014.11.001CrossRef

134.

Jiang XL, Samant S, Lesko LJ, Schmidt S (2015) Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet 54:147–166. https://doi.org/10.1007/s40262-014-0230-6CrossRefPubMedPubMedCentral

135.

Jørgensen IF, Aguayo-Orozco A, Lademann M, Brunak S (2020) Age-stratified longitudinal study of Alzheimer’s and vascular dementia patients. Alzheimers Dement 16:908–917. https://doi.org/10.1002/alz.12091CrossRefPubMedPubMedCentral

136.

Juma W, Lira A, Marzuk A, Marzuk Z, Hakim A, Thompson C (2011) C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Res 1414:85–93. https://doi.org/10.1016/j.brainres.2011.07.047CrossRefPubMed

137.

Justin BN, Turek M, Hakim AM (2013) Heart disease as a risk factor for dementia. Clin Epidemiol 5:135–145. https://doi.org/10.2147/clep.S30621CrossRefPubMedPubMedCentral

138.

Kakae M, Tobori S, Morishima M, Nagayasu K, Shirakawa H, Kaneko S (2019) Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model. Biochem Biophys Res Commun 514:1040–1044. https://doi.org/10.1016/j.bbrc.2019.05.055CrossRefPubMed

139.

Kalaria RN (2016) Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol 131:659–685. https://doi.org/10.1007/s00401-016-1571-zCrossRefPubMedPubMedCentral

140.

Kalaria RN (2018) The pathology and pathophysiology of vascular dementia. Neuropharmacology 134:226–239. https://doi.org/10.1016/j.neuropharm.2017.12.030CrossRefPubMed

141.

Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298:229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7CrossRefPubMedPubMedCentral

142.

Kang JH, Cook N, Manson J, Buring JE, Grodstein F (2007) Low dose aspirin and cognitive function in the women’s health study cognitive cohort. BMJ 334:987. https://doi.org/10.1136/bmj.39166.597836.BECrossRefPubMedPubMedCentral

143.

Katsura K-I, Kristián T, Smith M-L, Siesjö BK (1994) Acidosis induced by hypercapnia exaggerates ischemic brain damage. J Cereb Blood Flow Metab 14:243–250. https://doi.org/10.1038/jcbfm.1994.31CrossRefPubMed

144.

Kawahara M, Sadakane Y, Koyama H, Konoha K, Ohkawara S (2013) D-histidine and L-histidine attenuate zinc-induced neuronal death in GT1–7 cells. Metallomics Integr Biomet Sci 5(5):453–460CrossRef

145.

Kawamura J, Meyer JS, Terayama Y, Weathers S (1991) Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 22:609–614. https://doi.org/10.1161/01.STR.22.5.609CrossRefPubMed

146.

Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461CrossRefPubMedPubMedCentral

147.

Khan A, Kalaria RN, Corbett A, Ballard C (2016) Update on vascular dementia. J Geriatr Psychiatry Neurol 29:281–301. https://doi.org/10.1177/0891988716654987CrossRefPubMed

148.

Kiliaan AJ, Arnoldussen IA, Gustafson DR (2014) Adipokines: a link between obesity and dementia? Lancet Neurol 13:913–923. https://doi.org/10.1016/s1474-4422(14)70085-7CrossRefPubMedPubMedCentral

149.

Killeen MJ, Linder M, Pontoniere P, Crea R (2014) NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities. Drug Discovery Today 19:373–378. https://doi.org/10.1016/j.drudis.2013.11.002CrossRefPubMed

150.

Kim S, Choi SH, Lee YM, Kim MJ, Kim YD, Kim JY, Park JH, Myung W, Na HR, Han HJ et al (2015) Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study. Int Psychogeriatr 27:2069–2077. https://doi.org/10.1017/S1041610215001076CrossRefPubMed

151.

Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM (2020) World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement 16:1078–1094CrossRefPubMedPubMedCentral

152.

Kokko JP (1984) Site and mechanism of action of diuretics. Am J Med 77:11–17. https://doi.org/10.1016/s0002-9343(84)80003-0CrossRefPubMed

153.

Kokmen E, Whisnant JP, O’Fallon WM, Chu CP, Beard CM (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46:154–159. https://doi.org/10.1212/wnl.46.1.154CrossRefPubMed

154.

Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C (2005) Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 64:1548–1552. https://doi.org/10.1212/01.Wnl.0000160115.55756.DeCrossRefPubMed

155.

Lanza G, Cantone M, Musso S, Borgione E, Scuderi C, Ferri R (2018) Early-onset subcortical ischemic vascular dementia in an adult with mtDNA mutation 3316G>A. J Neurol 265:968–969. https://doi.org/10.1007/s00415-018-8795-xCrossRefPubMed

156.

Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58:498–504. https://doi.org/10.1001/archneur.58.3.498CrossRefPubMed

157.

Lautenschlager NT, Cox K, Cyarto EV (2012) The influence of exercise on brain aging and dementia. Biochim Biophys Acta (BBA) Mol Basis Dis 1822:474–481. https://doi.org/10.1016/j.bbadis.2011.07.010CrossRef

158.

Leblanc GG, Meschia JF, Stuss DT, Hachinski V (2006) Genetics of vascular cognitive impairment. Stroke 37:248–255. https://doi.org/10.1161/01.STR.0000195177.61184.49CrossRefPubMed

159.

Lejri I, Grimm A, Eckert A (2018) Mitochondria, estrogen and female brain aging. Front Aging Neurosci 10:124–124. https://doi.org/10.3389/fnagi.2018.00124CrossRefPubMedPubMedCentral

160.

Lenglet S, Montecucco F, Mach F, Schaller K, Gasche Y, Copin J-C (2017) Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost 112:363–378. https://doi.org/10.1160/TH14-01-0007CrossRef

161.

Leuner K, Müller W, Reichert A (2012) From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer’s disease. Mol Neurobiol 46:186–193. https://doi.org/10.1007/s12035-012-8307-4CrossRefPubMed

162.

Li H, Liu Y, Lin LT, Wang XR, Du SQ, Yan CQ, He T, Yang JW, Liu CZ (2016) Acupuncture reversed hippocampal mitochondrial dysfunction in vascular dementia rats. Neurochem Int 92:35–42. https://doi.org/10.1016/j.neuint.2015.12.001CrossRefPubMed

163.

Lin J, Wang D, Lan L, Fan Y (2017) Multiple factors involved in the pathogenesis of white matter lesions. Biomed Res Int 2017:9372050. https://doi.org/10.1155/2017/9372050CrossRefPubMedPubMedCentral

164.

Lindén T, Skoog I, Fagerberg B, Steen B, Blomstrand C (2004) Cognitive impairment and dementia 20 months after stroke. Neuroepidemiology 23:45–52. https://doi.org/10.1159/000073974CrossRefPubMed

165.

Ling C, Liu Z, Song M, Zhang W, Wang S, Liu X, Ma S, Sun S, Fu L, Chu Q et al (2019) Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells. Protein Cell 10:249–271. https://doi.org/10.1007/s13238-019-0608-1CrossRefPubMedPubMedCentral

166.

Liu H, Zhang J (2012) Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int J Neurosci 122:494–499. https://doi.org/10.3109/00207454.2012.686543CrossRefPubMed

167.

Liu Q, He S, Groysman L, Shaked D, Russin J, Scotton TC, Cen S, Mack WJ (2013) White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition. PLoS ONE 8:e84802. https://doi.org/10.1371/journal.pone.0084802CrossRefPubMedPubMedCentral

168.

Ma Y, Liu Y, Zhang Z, Yang G-Y (2019) Significance of complement system in ischemic stroke: a comprehensive review. Aging Dis 10:429–462. https://doi.org/10.14336/AD.2019.0119CrossRefPubMedPubMedCentral

169.

Magami S, Miyamoto N, Ueno Y, Hira K, Tanaka R, Yamashiro K, Oishi H, Arai H, Urabe T, Hattori N (2019) The effects of astrocyte and oligodendrocyte lineage cell interaction on white matter injury under chronic cerebral hypoperfusion. Neuroscience 406:167–175. https://doi.org/10.1016/j.neuroscience.2019.03.004CrossRefPubMed

170.

Maloney B, Lahiri DK (2016) Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol 15:760–774. https://doi.org/10.1016/S1474-4422(16)00065-XCrossRefPubMed

171.

Man S, Ubogu E, Ransohoff R (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol 17:243–250. https://doi.org/10.1111/j.1750-3639.2007.00067.xCrossRefPubMedPubMedCentral

172.

Mancuso C, Scapagini G, Currò D, Stella AMG, Marco CD, Butterfield DA, Calabrese V (2007) Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. FBL 12:1107–1123

173.

Markus HS, Schmidt R (2019) Genetics of vascular cognitive impairment. Stroke 50:765–772. https://doi.org/10.1161/STROKEAHA.118.020379CrossRefPubMedPubMedCentral

174.

Masumura M, Hata R, Nagai Y, Sawada T (2001) Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci Res 39:401–412. https://doi.org/10.1016/S0168-0102(01)00195-XCrossRefPubMed

175.

Mathey E, Park S, Hughes R, Pollard J, Armati P, Barnett M, Taylor B, Dyck P, Kiernan M, Lin C (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2014-309697CrossRefPubMed

176.

Matsushita K, Kuriyama Y, Nagatsuka K, Nakamura M, Sawada T, Omae T (1994) Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 23:565–568. https://doi.org/10.1161/01.HYP.23.5.565CrossRefPubMed

177.

Matsuyama H, Shindo A, Shimada T, Yata K, Wakita H, Takahashi R, Tomimoto H (2020) Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome. Brain Res 1736:146779–146779. https://doi.org/10.1016/J.BRAINRES.2020.146779CrossRefPubMed

178.

Matute C (2011) Glutamate and ATP signalling in white matter pathology. J Anat 219:53–64. https://doi.org/10.1111/j.1469-7580.2010.01339.xCrossRefPubMedPubMedCentral

179.

Matute C, Ransom BR (2012) Roles of white matter in central nervous system pathophysiologies. ASN Neuro 4:e00079–e00079. https://doi.org/10.1042/AN20110060CrossRefPubMedPubMedCentral

180.

McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J et al (2016) Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med 14:129–129. https://doi.org/10.1186/s12916-016-0676-5CrossRefPubMedPubMedCentral

181.

McQueen J, Reimer M, Holland P, Manso Y, McLaughlin M, Fowler J, Horsburgh K (2014) Restoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusion. PLoS ONE 9:e87227–e87227. https://doi.org/10.1371/journal.pone.0087227CrossRefPubMedPubMedCentral

182.

Mekaj YH, Daci FT, Mekaj AY (2015) New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag 11:1449–1456. https://doi.org/10.2147/tcrm.S92222CrossRefPubMedPubMedCentral

183.

Miyamoto N, Magami S, Inaba T, Ueno Y, Hira K, Kijima C, Nakajima S, Yamashiro K, Urabe T, Hattori N (2020) The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion. Glia 68:1910–1924. https://doi.org/10.1002/glia.23814CrossRefPubMed

184.

Miyamoto N, Maki T, Shindo A, Liang AC, Maeda M, Egawa N, Itoh K, Lo EK, Lok J, Ihara M et al (2015) Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor. J Neurosci 35:14002–14008. https://doi.org/10.1523/jneurosci.1592-15.2015CrossRefPubMedPubMedCentral

185.

Montagne A, Nikolakopoulou AM, Zhao Z, Sagare AP, Si G, Lazic D, Barnes SR, Daianu M, Ramanathan A, Go A et al (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24(3):326–337. https://doi.org/10.1038/nm.4482CrossRefPubMedPubMedCentral

186.

Morris MC (2016) Nutrition and risk of dementia: overview and methodological issues. Ann N Y Acad Sci 1367:31–37. https://doi.org/10.1111/nyas.13047CrossRefPubMedPubMedCentral

187.

Morris MC (2012) Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc 71:1–13. https://doi.org/10.1017/s0029665111003296CrossRefPubMed

188.

Morris MC, Tangney CC (2014) Dietary fat composition and dementia risk. Neurobiol Aging 35(Suppl 2):S59-64. https://doi.org/10.1016/j.neurobiolaging.2014.03.038CrossRefPubMed

189.

Mracskó E, Hugyecz M, Institoris A, Farkas E, Bari F (2009) Changes in pro-oxidant and antioxidant enzyme levels during cerebral hypoperfusion in rats. Brain Res 1321:13–19. https://doi.org/10.1016/j.brainres.2009.11.080CrossRefPubMed

190.

Nagai M, Hoshide S, Kario K (2010) Hypertension and dementia. Am J Hypertens 23:116–124. https://doi.org/10.1038/ajh.2009.212CrossRefPubMed

191.

Nation DA, Sweeney MD, Montagne A, Sagare AP, D’Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG et al (2019) Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270–276. https://doi.org/10.1038/s41591-018-0297-yCrossRefPubMedPubMedCentral

192.

Navarro A, Boveris A (2007) The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292:C670–C686. https://doi.org/10.1152/ajpcell.00213.2006CrossRefPubMed

193.

Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, Ives D, Dekosky ST, Kuller LH (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53:1101–1107. https://doi.org/10.1111/j.1532-5415.2005.53360.xCrossRefPubMed

194.

Nishio K, Ihara M, Yamasaki N, Kalaria R, Maki T, Fujita Y, Ito H, Oishi N, Fukuyama H, Miyakawa T et al (2010) A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke J Cereb Circ 41:1278–1284. https://doi.org/10.1161/STROKEAHA.110.581686CrossRef

195.

Niu XL, Jiang X, Xu GD, Zheng GM, Tang ZP, Yin N, Li XQ, Yang YY, Lv PY (2018) DL-3-n-butylphthalide alleviates vascular cognitive impairment by regulating endoplasmic reticulum stress and the Shh/Ptch1 signaling-pathway in rats. J Cell Physiol. https://doi.org/10.1002/jcp.27332CrossRefPubMed

196.

Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148:1145–1159. https://doi.org/10.1016/j.cell.2012.02.035CrossRefPubMedPubMedCentral

197.

O’Barr S, Cooper NR (2000) The C5a complement activation peptide increases IL-1β and IL-6 release from amyloid-β primed human monocytes: implications for Alzheimer’s disease. J Neuroimmunol 109:87–94. https://doi.org/10.1016/S0165-5728(00)00291-5CrossRefPubMed

198.

O’Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SCR, Markus HS (2002) Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59:321–326. https://doi.org/10.1212/WNL.59.3.321CrossRefPubMed

199.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS et al (2013) Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol Off J US Can Acad Pathol Inc 26:465–484. https://doi.org/10.1038/modpathol.2012.214CrossRef

200.

Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 310:970–973. https://doi.org/10.1136/bmj.310.6985.970CrossRefPubMedPubMedCentral

201.

Ozawa M, Ninomiya T, Ohara T, Doi Y, Uchida K, Shirota T, Yonemoto K, Kitazono T, Kiyohara Y (2013) Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr 97:1076–1082. https://doi.org/10.3945/ajcn.112.045575CrossRefPubMed

202.

Paciaroni M, Bogousslavsky J (2013) Connecting cardiovascular disease and dementia: further evidence. J Am Heart Assoc 2:e000656. https://doi.org/10.1161/jaha.113.000656CrossRefPubMedPubMedCentral

203.

Park J-M, Kim YJ, Song MK, Lee J-M, Kim Y-J (2018) Genome-wide DNA methylation profiling in a rat model with vascular dementia. Mol Med Rep 18:123–130. https://doi.org/10.3892/mmr.2018.8990CrossRefPubMedPubMedCentral

204.

Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 51:1256–1262. https://doi.org/10.2337/diabetes.51.4.1256CrossRefPubMed

205.

Phillips NA, Mate-Kole CC (1997) Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects. Stroke 28:777–784. https://doi.org/10.1161/01.str.28.4.777CrossRefPubMed

206.

Poh L, Fann DY, Wong P, Lim HM, Foo SL, Kang S-W, Rajeev V, Selvaraji S, Iyer VR, Parathy N et al (2021) AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia. Mol Psychiatry 26:4544–4560. https://doi.org/10.1038/s41380-020-00971-5CrossRefPubMed

207.

Poh L, Razak S, Lim HM, Lai MKP, Chen CL, Lim LHK, Arumugam TV, Fann DY (2021) AIM2 inflammasome mediates apoptotic and pyroptotic death in the cerebellum following chronic hypoperfusion. Exp Neurol 346:113856. https://doi.org/10.1016/j.expneurol.2021.113856CrossRefPubMed

208.

Portegies ML, Wolters FJ, Hofman A, Ikram MK, Koudstaal PJ, Ikram MA (2016) Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke 47:2119–2122. https://doi.org/10.1161/strokeaha.116.014094CrossRefPubMed

209.

Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R (2002) The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58:1175–1181. https://doi.org/10.1212/wnl.58.8.1175CrossRefPubMed

210.

Praticò D, Clark CM, Liun F, Lee VYM, Trojanowski JQ (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 59:972–976. https://doi.org/10.1001/archneur.59.6.972CrossRefPubMed

211.

Price BR, Wilcock DM, Weekman EM (2018) Hyperhomocysteinemia as a risk factor for vascular contributions to cognitive impairment and dementia. Front Aging Neurosci 10:350–350. https://doi.org/10.3389/fnagi.2018.00350CrossRefPubMedPubMedCentral

212.

Rafnsson SB, Deary IJ, Fowkes FG (2009) Peripheral arterial disease and cognitive function. Vasc Med 14:51–61. https://doi.org/10.1177/1358863x08095027CrossRefPubMed

213.

Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Jo DG, Drummond GR, Sobey CG, Lai MKP, Chen CL et al (2022) Intermittent fasting attenuates Hallmark vascular and neuronal pathologies in a mouse model of vascular cognitive impairment. Int J Biol Sci 18:6052–6067. https://doi.org/10.7150/ijbs.75188CrossRefPubMedPubMedCentral

214.

Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Lai MKP, Chen CL, Drummond GR, Sobey CG, Arumugam TV (2022) Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics 12:1639–1658. https://doi.org/10.7150/thno.68304CrossRefPubMedPubMedCentral

215.

Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, Mariani E, Licastro F, Patterson C (2007) Blood inflammatory markers and risk of dementia: the conselice study of brain aging. Neurobiol Aging 28:1810–1820. https://doi.org/10.1016/j.neurobiolaging.2006.08.012CrossRefPubMed

216.

Ravona-Springer R, Schnaider-Beeri M (2011) The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother 11:1609–1617. https://doi.org/10.1586/ern.11.152CrossRefPubMedPubMedCentral

217.

Reimer M, McQueen J, Searcy L, Scullion G, Desmazières A, Holland P, Smith J, Gliddon C, Wood E, Herzyk P et al (2011) Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci Off J Soc Neurosci 31:18185–18194. https://doi.org/10.1523/JNEUROSCI.4936-11.2011CrossRef

218.

Rizzuto R, De Stefani D, Raffaello A, Mammucari C (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13:566–578. https://doi.org/10.1038/nrm3412CrossRefPubMed

219.

Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC (2010) Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging 31:1894–1902. https://doi.org/10.1016/j.neurobiolaging.2008.10.018CrossRefPubMed

220.

Rohn TT, McCarty KL, Love JE, Head E (2014) Is apolipoprotein E4 an important risk factor for dementia in persons with down syndrome? J Parkinson’s Dis Alzheimer’s Dis 1:7–7. https://doi.org/10.13188/2376-922x.1000004CrossRef

221.

Román GC (2003) Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology 22:161–164. https://doi.org/10.1159/000069885CrossRefPubMed

222.

Román GC (2002) Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 203:7–10. https://doi.org/10.1016/S0022-510X(02)00252-6CrossRefPubMed

223.

Rosenberg GA, Sullivan N, Esiri MM (2001) White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32:1162–1167. https://doi.org/10.1161/01.STR.32.5.1162CrossRefPubMed

224.

Ruitenberg A, Den Heijer T, Bakker SLM, Van Swieten JC, Koudstaal PJ, Hofman A, Breteler MMB (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol 57:789–794. https://doi.org/10.1002/ANA.20493CrossRefPubMed

225.

Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD (2013) Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86508 men and women from the UK. Br J Psychiatry 203:10–17. https://doi.org/10.1192/bjp.bp.112.119479CrossRefPubMedPubMedCentral

226.

Rygiel K (2016) Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer’s disease? An overview of research evidence in the elderly patient population. J Postgrad Med 62:242–248. https://doi.org/10.4103/0022-3859.188553CrossRefPubMedPubMedCentral

227.

Sabayan B, Jansen S, Oleksik AM, van Osch MJP, van Buchem MA, van Vliet P, de Craen AJM, Westendorp RGJ (2012) Cerebrovascular hemodynamics in Alzheimer’s disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Res Rev 11:271–277. https://doi.org/10.1016/j.arr.2011.12.009CrossRefPubMed

228.

Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer D, Chen C, Chui H (2014) Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28:206–206CrossRefPubMedPubMedCentral

229.

Saito A (2014) Physiological functions of endoplasmic reticulum stress transducer OASIS in central nervous system. Anat Sci Int 89:11–20. https://doi.org/10.1007/s12565-013-0214-xCrossRefPubMed

230.

Saridin FN, Hilal S, Villaraza SG, Reilhac A, Gyanwali B, Tanaka T, Stephenson MC, Ng SL, Vrooman H, van der Flier WM et al (2020) Brain amyloid β, cerebral small vessel disease, and cognition. Neurology 95:e2845–e2853. https://doi.org/10.1212/WNL.0000000000011029CrossRefPubMed

231.

Scheel P, Puls I, Becker G, Schöning M (1999) Volume reduction in cerebral blood flow in patients with vascular dementia. Lancet 354:2137–2137. https://doi.org/10.1016/S0140-6736(99)04016-7CrossRefPubMed

232.

Schmidt R, Schmidt H, Curb J, Masaki K, White L, Launer L (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 52:168–174. https://doi.org/10.1002/ana.10265CrossRefPubMed

233.

Schmitz T, Chew L-J (2008) Cytokines and myelination in the central nervous system. TheScientificWorldJOURNAL 8:1119–1147. https://doi.org/10.1100/tsw.2008.140CrossRefPubMedPubMedCentral

234.

Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC et al (2009) Cerebral blood flow in ischemic vascular dementia and Alzheimer’s disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 5:454–462. https://doi.org/10.1016/J.JALZ.2009.04.1233CrossRefPubMedPubMedCentral

235.

Schuit AJ, Feskens MEJ, Launer LJ, Kromhout D (2001) Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc 33:772CrossRefPubMed

236.

Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J (2018) Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health 3:e124–e132. https://doi.org/10.1016/s2468-2667(18)30022-7CrossRefPubMed

237.

Selvaraji S, Efthymios M, Foo RSY, Fann DY, Lai MKP, Chen CLH, Lim KL, Arumugam TV (2022) Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia. Theranostics 12:3007–3023. https://doi.org/10.7150/thno.71815CrossRefPubMedPubMedCentral

238.

Shabir O, Berwick J, Francis S (2018) Neurovascular dysfunction in vascular dementia, Alzhiemers and atherosclerosis. BMC Neurosci. https://doi.org/10.1186/s12868-018-0465-5CrossRefPubMedPubMedCentral

239.

Sharp ES, Gatz M (2011) Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord 25:289–304. https://doi.org/10.1097/WAD.0b013e318211c83cCrossRefPubMedPubMedCentral

240.

Shen Y, Halperin JA, Lee C-M (1995) Complement-mediated neurotoxicity is regulated by homologous restriction. Brain Res 671:282–292. https://doi.org/10.1016/0006-8993(94)01264-ICrossRefPubMed

241.

Shi G-X, Liu C-Z, Wang L-P, Guan L-P, Li S-Q (2012) Biomarkers of oxidative stress in vascular dementia patients. Can J Neurol Sci J Can Sci Neurol 39:65–68. https://doi.org/10.1017/S0317167100012701CrossRef

242.

Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35:2598–2603. https://doi.org/10.1161/01.Str.0000143725.19053.60CrossRefPubMed

243.

Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R, Ihara M, Takahashi R, Tomimoto H (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38:2826–2832. https://doi.org/10.1161/STROKEAHA.107.490151CrossRefPubMed

244.

Silva IVG, de Figueiredo RC, Rios DRA (2019) Effect of different classes of antihypertensive drugs on endothelial function and inflammation. Int J Mol Sci. https://doi.org/10.3390/ijms20143458CrossRefPubMedPubMedCentral

245.

Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, O’Brien JT, Barber R, Kalaria RN, Brayne C et al (2007) White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 33:410–419. https://doi.org/10.1111/j.1365-2990.2007.00828.xCrossRefPubMed

246.

Skoog I (1998) Status of risk factors for vascular dementia. Neuroepidemiology 17:2–9. https://doi.org/10.1159/000026147CrossRefPubMed

247.

Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J et al (2016) Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 139:2957–2969. https://doi.org/10.1093/brain/aww214CrossRefPubMed

248.

Sofroniew MV (2014) Astrogliosis. Cold Spring Harb Perspect Biol 7:a020420–a020420. https://doi.org/10.1101/cshperspect.a020420CrossRefPubMed

249.

Son H-H, Pt OhMS, Jung L, Pt PMS, Rae J, Pt PhD (2010) The effect of an exercise program on activities of daily living (ADL), balance and cognition in elderly individuals with Alzheimer’s disease and vascular dementia. J Korean Phys Ther 22:53–60

250.

Stamatovic SM, Johnson AM, Keep RF, Andjelkovic AV (2016) Junctional proteins of the blood–brain barrier: new insights into function and dysfunction. Tissue Barriers. https://doi.org/10.1080/21688370.2016.1154641CrossRefPubMedPubMedCentral

251.

Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044–1049. https://doi.org/10.1056/nejm198510243131703CrossRefPubMed

252.

Stanimirovic DB, Friedman A (2012) Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metabol 32:1207–1221. https://doi.org/10.1038/jcbfm.2012.25CrossRef

253.

Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 271:1004–1010CrossRefPubMed

254.

Stewart R (2002) Vascular dementia: a diagnosis running out of time. Br J Psychiatry 180:152–156. https://doi.org/10.1192/bjp.180.2.152CrossRefPubMed

255.

Stys PK, Waxman SG, Ransom BR (1992) Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na⁺ channels and Na⁽⁺⁾–Ca²⁺ exchanger. J Neurosci 12:430–439. https://doi.org/10.1523/JNEUROSCI.12-02-00430.1992CrossRefPubMedPubMedCentral

256.

Sudduth TL, Powell DK, Smith CD, Greenstein A, Wilcock DM (2013) Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J Cereb Blood Flow Metab 33:708–715. https://doi.org/10.1038/jcbfm.2013.1CrossRefPubMedPubMedCentral

257.

Sun Z-K, Ma XR, Jia YJ, Liu YR, Zhang JW, Zhang BA (2014) Effects of resveratrol on apoptosis in a rat model of vascular dementia. Exp Ther Med 7:843–848. https://doi.org/10.3892/etm.2014.1542CrossRefPubMedPubMedCentral

258.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ (2019) Vascular dysfunction—the disregarded partner of Alzheimer’s disease. Alzheimers Dement 15:158–167CrossRefPubMedPubMedCentral

259.

Takeshita Y, Ransohoff RM (2012) Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev 248:228–239. https://doi.org/10.1111/j.1600-065X.2012.01127.xCrossRefPubMedPubMedCentral

260.

Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820. https://doi.org/10.1016/j.cell.2010.01.022CrossRefPubMed

261.

Tampi RR, Tampi DJ, Balachandran S, Srinivasan S (2016) Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis 7:229–245. https://doi.org/10.1177/2040622316658463CrossRefPubMedPubMedCentral

262.

Tan R, Traylor M, Rutten-Jacobs L, Markus H (2017) New insights into mechanisms of small vessel disease stroke from genetics. Clin Sci 131:515–531. https://doi.org/10.1042/cs20160825CrossRef

263.

Tanaka K-I, Kawahara M (2017) Copper enhances zinc-induced neurotoxicity and the endoplasmic reticulum stress response in a neuronal model of vascular dementia. Front Neurosci 11:58–58. https://doi.org/10.3389/fnins.2017.00058CrossRefPubMedPubMedCentral

264.

Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G (2019) The molecular machinery of regulated cell death. Cell Res 29:347–364. https://doi.org/10.1038/s41422-019-0164-5CrossRefPubMedPubMedCentral

265.

Tanovic A, Alfaro V (2006) Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer’s disease and vascular dementia. Rev Neurol 42:607–616. https://doi.org/10.33588/rn.4210.2005252CrossRefPubMed

266.

Tarumi T, Shah F, Tanaka H, Haley AP (2011) Association between central elastic artery stiffness and cerebral perfusion in deep subcortical gray and white matter. Am J Hypertens 24:1108–1113. https://doi.org/10.1038/ajh.2011.101CrossRefPubMed

267.

Tasci I, Safer U, Naharci MI, Gezer M, Demir O, Bozoglu E, Doruk H (2018) Undetected peripheral arterial disease among older adults with Alzheimer’s disease and other dementias. Am J Alzheimers Dis Other Demen 33:5–11. https://doi.org/10.1177/1533317517724000CrossRefPubMed

268.

Tham W, Auchus AP, Thong M, Goh M-L, Chang H-M, Wong M-C, Chen CPLH (2002) Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci 203:49–52. https://doi.org/10.1016/S0022-510X(02)00260-5CrossRefPubMed

269.

Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, Kimura J (1996) Alterations of the blood–brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer’s disease patients. Stroke 27:2069–2074. https://doi.org/10.1161/01.STR.27.11.2069CrossRefPubMed

270.

Topiwala A, Allan CL, Valkanova V, Zsoldos E, Filippini N, Sexton C, Mahmood A, Fooks P, Singh-Manoux A, Mackay CE et al (2017) Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ 357:j2353. https://doi.org/10.1136/bmj.j2353CrossRefPubMedPubMedCentral

271.

Toth P, Tarantini S, Csiszar A, Ungvari Z (2017) Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol 312:H1–H20. https://doi.org/10.1152/AJPHEART.00581.2016CrossRefPubMed

272.

Toyama K, Koibuchi N, Uekawa K, Hasegawa Y, Kataoka K, Katayama T, Sueta D, Ma MJ, Nakagawa T, Yasuda O et al (2014) Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion. Arterioscler Thromb Vasc Biol 34:616–625. https://doi.org/10.1161/ATVBAHA.113.302440CrossRefPubMed

273.

Tripolt NJ, Stekovic S, Aberer F, Url J, Pferschy PN, Schröder S, Verheyen N, Schmidt A, Kolesnik E, Narath SH et al (2018) Intermittent fasting (alternate day fasting) in healthy, non-obese adults: protocol for a cohort trial with an embedded randomized controlled pilot trial. Adv Ther 35:1265–1283. https://doi.org/10.1007/s12325-018-0746-5CrossRefPubMedPubMedCentral

274.

Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, Rosenberg IH (2008) B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A 105:12474–12479. https://doi.org/10.1073/pnas.0805350105CrossRefPubMedPubMedCentral

275.

Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O’Brien RJ (2008) Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 64:168–176. https://doi.org/10.1002/ana.21413CrossRefPubMedPubMedCentral

276.

Truettner JS, Alonso OF, Dietrich WD (2005) Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats. J Cereb Blood Flow Metab 25:1505–1516. https://doi.org/10.1038/SJ.JCBFM.9600150CrossRefPubMed

277.

Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H (2016) Blood–brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 22:97–104. https://doi.org/10.1097/00004647-200201000-00012CrossRef

278.

Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A (2010) Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 65:1028–1041. https://doi.org/10.1093/gerona/glq113CrossRefPubMed

279.

Utech M, Mennigen R, Bruewer M (2010) Endocytosis and recycling of tight junction proteins in inflammation. J Biomed Biotechnol. https://doi.org/10.1155/2010/484987CrossRefPubMed

280.

van de Rest O, Berendsen AA, Haveman-Nies A, de Groot LC (2015) Dietary patterns, cognitive decline, and dementia: a systematic review. Adv Nutr 6:154–168. https://doi.org/10.3945/an.114.007617CrossRefPubMedPubMedCentral

281.

van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P (2018) Vascular cognitive impairment. Nat Rev Dis Primers 4(1):1–16. https://doi.org/10.1038/nrdp.2018.3CrossRef

282.

Varatharaj A, Galea I (2017) The blood–brain barrier in systemic inflammation. Brain Behav Immun 60:1–12. https://doi.org/10.1016/j.bbi.2016.03.010CrossRefPubMed

283.

Venkat P, Chopp M, Chen J (2015) Models and mechanisms of vascular dementia. Exp Neurol 272:97–108. https://doi.org/10.1016/J.EXPNEUROL.2015.05.006CrossRefPubMedPubMedCentral

284.

Verbaten MN (2009) Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not? Hum Psychopharmacol 24:199–205. https://doi.org/10.1002/hup.1022CrossRefPubMed

285.

Verdelho A, Madureira S, Ferro JM, Baezner H, Blahak C, Poggesi A, Hennerici M, Pantoni L, Fazekas F, Scheltens P et al (2012) Physical activity prevents progression for cognitive impairment and vascular dementia. Stroke 43:3331–3335. https://doi.org/10.1161/STROKEAHA.112.661793CrossRefPubMed

286.

Vernooij MW, Van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, Krestin GP, Breteler MM (2007) Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam scan study. J Cereb Blood Flow Metab 28:412–419. https://doi.org/10.1038/SJ.JCBFM.9600526CrossRefPubMed

287.

Wallace DC (2001) A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235:247–263. https://doi.org/10.1002/0470868694.ch20CrossRefPubMed

288.

Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG, Lossi L, Malojcic B et al (2017) Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease—a consensus report. BMC Neurol 17:102–102. https://doi.org/10.1186/s12883-017-0877-3CrossRefPubMedPubMedCentral

289.

Wang S, Cao C, Chen Z, Bankaitis V, Tzima E, Sheibani N, Burridge K (2012) Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS ONE 7:e45499. https://doi.org/10.1371/journal.pone.0045499CrossRefPubMedPubMedCentral

290.

Wang T, Liu CZ, Yu JC, Jiang W, Han JX (2009) Acupuncture protected cerebral multi-infarction rats from memory impairment by regulating the expression of apoptosis related genes Bcl-2 and Bax in hippocampus. Physiol Behav 96:155–161. https://doi.org/10.1016/j.physbeh.2008.09.024CrossRefPubMed

291.

Ward NC, Watts GF, Eckel RH (2019) Statin toxicity. Circ Res 124:328–350. https://doi.org/10.1161/circresaha.118.312782CrossRefPubMed

292.

Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Maniega SM, Farrall A, Sudlow C, Dennis M, Dhillon B (2009) Lacunar stroke is associated with diffuse blood–brain barrier dysfunction. Ann Neurol 65:194–202. https://doi.org/10.1002/ANA.21549CrossRefPubMed

293.

Webb AJS, Simoni M, Mazzucco S, Kuker W, Schulz U, Rothwell PM (2012) Increased cerebral arterial pulsatility in patients with leukoaraiosis. Stroke 43:2631–2636. https://doi.org/10.1161/STROKEAHA.112.655837CrossRefPubMed

294.

Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Østbye T, Wolfson C, Gauthier S, Verreault R et al (2001) Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 57:714–716. https://doi.org/10.1212/WNL.57.4.714CrossRefPubMed

295.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH (2017) Beta-blockers for hypertension. Cochrane Database Syst Rev 1:Cd002003. https://doi.org/10.1002/14651858.CD002003.pub5CrossRefPubMed

296.

Wu C-x, Liu R, Gao M, Zhao G, Wu S, Wu C-f, Du G-h (2013) Pinocembrin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis. Neurosci Lett 546:57–62. https://doi.org/10.1016/j.neulet.2013.04.060CrossRefPubMed

297.

Wu L-Y, Kan CN, Cheah IK, Chong JR, Xu X, Vrooman H, Hilal S, Venketasubramanian N, Chen CP, Halliwell B et al (2022) Low plasma ergothioneine predicts cognitive and functional decline in an elderly cohort attending memory clinics. Antioxidants 11:1717CrossRefPubMedPubMedCentral

298.

Wu LY, Cheah IK, Chong JR, Chai YL, Tan JY, Hilal S, Vrooman H, Chen CP, Halliwell B, Lai MKP (2021) Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia. Free Radic Biol Med 177:201–211. https://doi.org/10.1016/j.freeradbiomed.2021.10.019CrossRefPubMed

299.

Wu X, Sun J, Li L (2013) Chronic cerebrovascular hypoperfusion affects global DNA methylation and histone acetylation in rat brain. Neurosci Bull 29:685–692. https://doi.org/10.1007/s12264-013-1345-8CrossRefPubMedPubMedCentral

300.

Xiang C, Wang Y, Zhang H, Han F (2017) The role of endoplasmic reticulum stress in neurodegenerative disease. Apoptosis 22:1–26. https://doi.org/10.1007/s10495-016-1296-4CrossRefPubMed

301.

Xiong Z-G, Zhu X-M, Chu X-P, Minami M, Hey J, Wei W-L, MacDonald JF, Wemmie JA, Price MP, Welsh MJ et al (2004) Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118:687–698. https://doi.org/10.1016/j.cell.2004.08.026CrossRefPubMed

302.

Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L (2009) Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58:71–77. https://doi.org/10.2337/db08-0586CrossRefPubMedPubMedCentral

303.

Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: the radiation effects research foundation adult health study. J Am Geriatr Soc 51:410–414. https://doi.org/10.1046/j.1532-5415.2003.51117.xCrossRefPubMed

304.

Yang T, Sun Y, Lu Z, Leak RK, Zhang F (2017) The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev 34:15–29. https://doi.org/10.1016/j.arr.2016.09.007CrossRefPubMed

305.

Yang Y, Jiang G, Zhang P, Fan J (2015) Programmed cell death and its role in inflammation. Mil Med Res 2:12–12. https://doi.org/10.1186/s40779-015-0039-0CrossRefPubMedPubMedCentral

306.

Yang Z, Zhang N, Shen H, Lin C, Lin L, Yuan B (2014) Microglial activation with reduction in autophagy limits white matter lesions and improves cognitive defects during cerebral hypoperfusion. Curr Neurovasc Res 11:223–229. https://doi.org/10.2174/1567202611666140520124407CrossRefPubMed

307.

Yarlagadda A, Alfson E, Clayton AH (2009) The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry 6:18–18PubMedPubMedCentral

308.

Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R (2020) Influence of comorbidity of cerebrovascular disease and amyloid-β on Alzheimer’s disease. J Alzheimers Dis 73:897–907CrossRefPubMed

309.

Yenari MA, Kauppinen TM, Swanson RA (2010) Microglial activation in stroke: therapeutic targets. Neurother J Am Soc Exp NeuroTher 7:378–391. https://doi.org/10.1016/j.nurt.2010.07.005CrossRef

310.

Yin F, Boveris A, Cadenas E (2014) Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal 20:353–371. https://doi.org/10.1089/ars.2012.4774CrossRefPubMedPubMedCentral

311.

Zhang LY, Pan J, Mamtilahun M, Zhu Y, Wang L, Venkatesh A, Shi R, Tu X, Jin K, Wang Y et al (2020) Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion. Theranostics 10:74–90. https://doi.org/10.7150/thno.35841CrossRefPubMedPubMedCentral

312.

Zheng Y, Zhang J, Zhao Y, Zhang Y, Zhang X, Guan J, Liu Y, Fu J (2020) Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis. Int Immunopharmacol 93:107422CrossRefPubMed

313.

Zhou Y, Zhang J, Wang L, Chen Y, Wan Y, He Y, Jiang L, Ma J, Liao R, Zhang X et al (2017) Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion. Brain Behav Immun 60:93–105. https://doi.org/10.1016/j.bbi.2016.09.024CrossRefPubMed

314.

Zhu Y, Chai YL, Hilal S, Ikram MK, Venketasubramanian N, Wong B-S, Chen CP, Lai MKP (2017) Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer’s disease. Alzheimer’s Dement 7:41–47. https://doi.org/10.1016/j.dadm.2017.01.001CrossRef

315.

Zhu Y, Hilal S, Chai YL, Ikram MK, Venketasubramanian N, Chen CP, Lai MKP (2018) Serum hepatocyte growth factor is associated with small vessel disease in Alzheimer’s dementia. Front Aging Neurosci 10:8–8. https://doi.org/10.3389/fnagi.2018.00008CrossRefPubMedPubMedCentral

316.

Zuccalà G, Onder G, Pedone C, Carosella L, Pahor M, Bernabei R, Cocchi A (2001) Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 57:1986–1992. https://doi.org/10.1212/wnl.57.11.1986CrossRefPubMed

317.

Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti A, Ble A, Fellin R (2007) Plasma cytokine profile in older subjects with late onset Alzheimer’s disease or vascular dementia. J Psychiatr Res 41:686–693. https://doi.org/10.1016/j.jpsychires.2006.02.008CrossRefPubMed

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Cryo-EM structures of Aβ40 filaments from the leptomeninges of individuals with Alzheimer’s disease and cerebral amyloid angiopathy

MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice

Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain

Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity

Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer’s disease